To assess the efficacy of intraperitoneal 0.25% levobupivacaine for postoperative analgesia following laparoscopic cholecystectomy
Phase 1
Completed
- Conditions
- Health Condition 1: K00-K95- Diseases of the digestive system
- Registration Number
- CTRI/2019/08/020837
- Lead Sponsor
- Pavithra Palaniappan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 56
Inclusion Criteria
Patients undergoing laparoscopic cholecystectomy
Patients of ASA1 and ASA 2
Exclusion Criteria
Patients allergic to local anaesthetics
Patients with severe cardiac, pulmonary, and neurological disease
Patients in whom procedure has to be converted to open cholecystectomy
Patients in whom abdominal drain will be kept
Patients of weight less than 50 kg
Patients not willing to participate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time for the first request of analgesia within first 24 hoursTimepoint: Time for the first request of analgesia within first 24 hours
- Secondary Outcome Measures
Name Time Method Post operative VAS score <br/ ><br>Total no. of analgesics used in first 24 hrsTimepoint: 24 hrs